Cargando…
Can proton therapy be considered a standard of care in oncology? Lessons from the United States
Autor principal: | Zietman, Anthony L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474263/ https://www.ncbi.nlm.nih.gov/pubmed/30911089 http://dx.doi.org/10.1038/s41416-018-0324-2 |
Ejemplares similares
-
Peritoneal Dialysis in the United States: Lessons for the Future
por: Hansson, Joni H., et al.
Publicado: (2020) -
A (relatively) risky business: the link between prostatic radiotherapy and second malignancies
por: Eyler, Christine E, et al.
Publicado: (2016) -
Proton beam therapy and localised prostate cancer: current status and
controversies
por: Efstathiou, J A, et al.
Publicado: (2013) -
Can We Consider PR Interval to Screen Patients for Cardiac
Resynchronization Therapy?
por: Martinelli Filho, Martino
Publicado: (2018) -
Patient reported outcomes in thoracic trauma—lesson learned from thoracic oncology
por: Gooseman, Michael R., et al.
Publicado: (2023)